Fosphenytoin Sodium - Drug Shortage Information

Public shortage context is available across 8 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Historical shortage references are available across related Fosphenytoin Sodium presentations from multiple manufacturers.

0 current shortage context pages.
8 historical shortage context pages.
4 manufacturers represented.

Related research paths

Fosphenytoin Sodium catalog familyBrowse all visible Fosphenytoin Sodium presentations in the broader catalog.Fresenius Kabi USA, LLC2 shortage-bearing exact NDC pages.Hikma Pharmaceuticals USA Inc.2 shortage-bearing exact NDC pages.Pfizer Laboratories Div Pfizer Inc2 shortage-bearing exact NDC pages.

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Fosphenytoin Sodium 50 mg / mL Injection 2 mL - NDC 63323-0403-02Fresenius Kabi USA, LLC | 25 Vial Fosphenytoin Sodium 50 mg / mL Injection 10 mL - NDC 63323-0403-10Fresenius Kabi USA, LLC | 10 Vial Fosphenytoin Sodium 50 mg / mL Injection 2 mL - NDC 00641-6136-25Hikma Pharmaceuticals USA Inc. | 25 Vial Fosphenytoin Sodium 50 mg / mL Injection 10 mL - NDC 00641-6137-10Hikma Pharmaceuticals USA Inc. | 10 Vial Fosphenytoin Sodium 50 mg / mL Injection 2 mL (Cerebyx) - NDC 00069-5471-02Pfizer Laboratories Div Pfizer Inc | 25 Vial, Single-Dose

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug Name	NDC 11	Manufacturer	Shortage Context
Fosphenytoin Sodium 50 mg / mL Injection 2 mL NDC 63323-0403-02 \| 25 Vial \| Fresenius Kabi USA, LLC	63323-0403-02	Fresenius Kabi USA, LLC	Historical shortage context
Fosphenytoin Sodium 50 mg / mL Injection 10 mL NDC 63323-0403-10 \| 10 Vial \| Fresenius Kabi USA, LLC	63323-0403-10	Fresenius Kabi USA, LLC	Historical shortage context
Fosphenytoin Sodium 50 mg / mL Injection 2 mL NDC 00641-6136-25 \| 25 Vial \| Hikma Pharmaceuticals USA Inc.	00641-6136-25	Hikma Pharmaceuticals USA Inc.	Historical shortage context
Fosphenytoin Sodium 50 mg / mL Injection 10 mL NDC 00641-6137-10 \| 10 Vial \| Hikma Pharmaceuticals USA Inc.	00641-6137-10	Hikma Pharmaceuticals USA Inc.	Historical shortage context
Fosphenytoin Sodium 50 mg / mL Injection 2 mL (Cerebyx) NDC 00069-5471-02 \| 25 Vial, Single-Dose \| Pfizer Laboratories Div Pfizer Inc	00069-5471-02	Pfizer Laboratories Div Pfizer Inc	Historical shortage context
Fosphenytoin Sodium 50 mg / mL Injection 10 mL (Cerebyx) NDC 00069-6001-21 \| 10 Vial \| Pfizer Laboratories Div Pfizer Inc	00069-6001-21	Pfizer Laboratories Div Pfizer Inc	Historical shortage context
Fosphenytoin Sodium 50 mg / mL Injection 10 mL NDC 00143-9782-10 \| 10 Vial \| West-Ward Pharmaceuticals Corp	00143-9782-10	West-Ward Pharmaceuticals Corp	Historical shortage context
Fosphenytoin Sodium 50 mg / mL Injection 2 mL NDC 00143-9788-25 \| 25 Vial \| West-Ward Pharmaceuticals Corp	00143-9788-25	West-Ward Pharmaceuticals Corp	Historical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.